Comparison of immunogenicity between codon optimized HIV-1 Thailand subtype B gp140 and gp145 vaccines
- 21 June 2007
- Vol. 25 (26) , 4949-4959
- https://doi.org/10.1016/j.vaccine.2007.01.118
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Sequential priming and boosting with heterologous HIV immunogens predominantly stimulated T cell immunity against conserved epitopesAIDS, 2006
- HIV-1 Envgp140 trimers elicit neutralizing antibodies without efficient induction of conformational antibodiesVaccine, 2006
- Heterologous Envelope Immunogens Contribute to AIDS Vaccine Protection in Rhesus MonkeysJournal of Virology, 2004
- Selective Modification of Variable Loops Alters Tropism and Enhances Immunogenicity of Human Immunodeficiency Virus Type 1 EnvelopeJournal of Virology, 2004
- Modifications of the Human Immunodeficiency Virus Envelope Glycoprotein Enhance Immunogenicity for Genetic ImmunizationJournal of Virology, 2002
- Effect of the V3 Loop Deletion of Envelope Glycoprotein on Cellular Responses and Protection against Challenge with Recombinant Vaccinia Virus Expressing gp160 of Primary Human Immunodeficiency Virus Type 1 IsolatesJournal of Virology, 2002
- Prospects for Vaccine Protection Against HIV-1 Infection and AIDSAnnual Review of Immunology, 2002
- Ongoing trials of immune-based therapies for HIV infection in adultsExpert Opinion on Biological Therapy, 2001
- Induction of immune responses to HIV-1 by canarypox virus (ALVAC) HIV-1 and gp120 SF-2 recombinant vaccines in uninfected volunteersAIDS, 1998
- Neutralizing antibodies to HIV-1 in seronegative volunteers immunized with recombinant gp120 from the MN strain of HIV-1. NIAID AIDS Vaccine Clinical Trials NetworkJAMA, 1994